CI
Cigna Group
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 278.88
Buy <=wait / entry
USD 246.67
Trim >=take some off
USD 300.00
Thesis breakA formal PBM rebate or pricing action by a US federal regulator that materially ...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 43% | 100 / 100 | 43.0 |
| Base case | 49% | 62 / 100 | 30.4 |
| Bear case | 8% | 10 / 100 | 0.8 |
| Weighted conviction | 74 / 100 - BUY | ||
Top risks
- M&A activity: Acquisition of CarepathRx completed in February 2026
- Earnings or guidance changes: Multiple quarterly EPS beats including Q2 2026 actual $7.78 vs forecast $7.60, plus full-year 2026 EPS guidance support
- Earnings or guidance changes: Q1 2026 EPS beat and raised 2026 EPS guidance above $30.35